20354 Federal Register / Vol. 72, No.
78 / Tuesday April 24, 2007 / Notices
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neurotoxicology
and Alcohol Study Section.
Date: June 14–15, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Churchill Hotel, 1914 Connecticut
Avenue, NW., Washington, DC 20009.
Contact Person: Joseph G. Rudolph, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7844, Bethesda, MD 20892, 301–435–
2212, josephru@csr.nih.gov.
Name of Committee: Health of the
Population Integrated Review Group;
Epidemiology of Cancer Study Section.
Date: June 14–15, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Admiral Fell Inn, 888 South
Broadway, Baltimore, MD 21231.
Contact Person: Denise Wiesch, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3150,
MSC 7770, Bethesda, MD 20892, (301) 435–
0684, wieschd@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Immunity and Host
Defense Study Section.
Date: June 14–15, 2007.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza Hotel, 10 Thomas
Circle, NW., Washington, DC 20005.
Contact Person: Patrick K. Lai, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2215,
MSC 7812, Bethesda, MD 20892, 301–435–
1052, laip@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurogenesis and Cell Fate
Study Section.
Date: June 14–15, 2007.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave., NW., Washington, DC 20037.
Contact Person: Lawrence Baizer, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152,
MSC 7850, Bethesda, MD 20892, (301) 435–
1257, baizerl@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Synthetic and Biological
Chemistry B Study Section.
Date: June 14–15, 2007.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
jlentini on PROD1PC65 with NOTICES
applications.
Place: DoubleTree Hotel, 8120 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Mike Radtke, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
VerDate Aug<31>2005 18:32 Apr 23, 2007 Jkt 211001
Health, 6701 Rockledge Drive, Room 4176,
MSC 7806, Bethesda, MD 20892, 301–435–
1728, radtkem@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 17, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2035 Filed 4–23–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Opioid Drugs in Maintenance and
Detoxification Treatment of Opiate
Addiction; Public Notice of Revocation
of Certification
AGENCY: Substance Abuse and Mental
Health Services Administration
(SAMHSA), Department of Health and
Human Services.
ACTION: Notice.
SUMMARY: The Substance Abuse and
Mental Health Services Administration
has revoked the certification to provide
opioid assisted treatment for the three
opioid treatment programs listed below.
DATES: The revocation of certification
was effective on March 20, 2007.
FOR FURTHER INFORMATION CONTACT:
Nicholas Reuter, Center for Substance
Abuse Treatment (CSAT), Division of
Pharmacologic Therapies, SAMHSA,
One Choke Cherry Road, Rm 2–1063,
Rockville, MD 20857, (240) 276–2716, e-
mail: Nicholas.Reuter@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In a notice published in the Federal
Register of January 17, 2001 (66 FR
4076, January 17, 2001), the Substance
Abuse and Mental health Services
Administration (SAMHSA) issued final
regulations for the use of narcotic drugs
in maintenance and detoxification
treatment of opioid addiction. That final
rule established an accreditation-based
regulatory system under 42 CFR part 8
(‘‘Certification of Opioid Treatment
Programs,’’ ‘‘OTPs’’). The SAMHSA
regulations establish the standards for
determining that practitioners
(programs) are qualified for Drug
Enforcement Administration (DEA)
registration under 21 U.S.C. 821(g)(1).
Qualified programs are granted
certification.
PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\24APN1.SGM
The regulations establish the
conditions for certification as well as
the criteria for the suspension or
revocation of SAMHSA certification. In
addition, Subpart C sets forth the
procedures for review of suspension or
proposed revocation of OTP
certification.
The Administrator of SAMHSA
proposed to decertify these three
programs in August 2006. As set forth
under 42 CFR part 8, subpart C, each
OTP requested a review of the
Administrator’s proposal, and submitted
documents and briefs to a designated
reviewing official for consideration, that
were incorporated into an
administrative review record. After
considering the available information
and evidence, the reviewing officials, in
upholding the Administrator’s proposal
to revoke certification, found that the
OTPs listed below were in violation of
Federal Opioid Treatment Program
Regulations (42 CFR § 8.11,8.14).
1. New Horizon Rehabilitation
Services, 4809 W. Chicago Ave.,
Chicago, IL 60651.
2. Turning Point Treatment Center,
Inc., 210 Commerce St., Blairsville,
Georgia 30512.
3. Bay Area C.A.R.E. Center, Inc.,
3138 South Alameda, Corpus Christi,
Texas 78404.
Dated: April 13, 2007.
Terry L. Cline,
Administrator, Substance Abuse and Mental
Health Services Administration.
[FR Doc. 07–1994 Filed 4–23–07; 8:45 am]
BILLING CODE 4160–20–M
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5117–N–34]
Notice of Submission of Proposed
Information Collection to OMB;
Servicemembers Civil Relief
AGENCY: Office of the Chief Information
Officer, HUD.
ACTION: Notice.
SUMMARY: The proposed information
collection requirement described below
has been submitted to the Office of
Management and Budget (OMB) for
review, as required by the Paperwork
Reduction Act. The Department is
soliciting public comments on the
subject proposal.
Federal law requires lenders to send
a statement or notice to homeowners in
default explaining the mortgage and
foreclosure rights of servicemembers
and their dependents under the
Servicemembers Civil Relief Act (50
24APN1